1933 Industries Extends Expiry Date of Warrants

June 5, 2024 7:00 AM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis cultivator and producer, announces that it reached an agreement to amend the expiry date of its outstanding 3,700,000 warrants (the "Warrants"), from June 13, 2024, to November 9, 2025. The Warrants were originally issued on November 9, 2020, and have an exercise price of $0.075. The exercise price and all other terms of the Warrants will...

Read more

Bioz and Quantabio Launch AI-Driven Citation Widgets to Provide Researchers With Real-Time Application Data

June 5, 2024 4:00 AM

PALO ALTO, CA / ACCESSWIRE / June 5, 2024 / Bioz, Inc., an innovative AI software company based in Silicon Valley, is excited to announce its partnership with Quantabio, a leading provider of advanced DNA and RNA amplification reagents for the most demanding molecular testing applications in applied, translational and life science research. With over 20,000 citations in the scientific literature, this partnership aims to highlight Quantabio's...

Read more

Stanford Blood Donor Center Chooses the HemoFlow 500 and HemoVue Cloud Service to Streamline Its Whole Blood Collection Operations

June 4, 2024 6:00 PM

GRASS VALLEY, CA / ACCESSWIRE / June 4, 2024 / Applied Science, the worldwide leader in whole blood collection products and services, today announced that Stanford Blood Center has purchased ASI's next- generation device, the HemoFlow 500 and HemoVue, its recently introduced cloud-based service that works with HemoFlow devices to provide real-time operational data and analytics that significantly improve blood collection and related processes....

Read more

Xcelerate, Inc. Addresses Concerns About Recently Released Research Report

June 4, 2024 4:15 PM

Xcelerate, Inc. (OTCQB:XCRT) today announced that it has become aware of an independent research report released by Harbinger Research earlier in the day that contains erroneous information about the Company and has reached out to the author of the report to advise of the same. Mike O'Shea, Xcelerate's CEO said "While we were aware that this independent report was being prepared, we had no prior knowledge of the contents of the report. Upon our...

Read more

Curiteva Surpasses 1,000 Procedures With Inspire(R) Cervical Trabecular PEEK(TM) With HAFUSE(R) Technology

June 4, 2024 1:00 PM

HUNTSVILLE, AL / ACCESSWIRE / June 4, 2024 / Curiteva, Inc., a privately held manufacturing and technology company, announces over 1,000 patients have been treated with the novel 3D printed Inspire Cervical Trabecular PEEK Interbody Fusion System, resulting in over 2,000 Inspire implants placed in patients. The Inspire Cervical System was introduced with limited launch in April of 2023, followed by full commercialization in July. "I am seeing CT...

Read more

Which Vendors Are Perceived as Ready for the Cloud: AGFA HealthCare’s Enterprise Imaging Customers Show Confidence in AGFA HealthCare’s Cloud Strategy, Reports KLAS Research

June 4, 2024 11:20 AM

MORTSEL, BELGIUM / ACCESSWIRE / June 4, 2024 / Entitled "Imaging in the Cloud 2024", the segment insights report from KLAS Research focuses on healthcare organizations' perceptions of their imaging vendors' cloud strategies. The report's intention is to offer an overview of the state of cloud adoption to organizations who are considering the cloud. It is well known that the U.S. healthcare imaging market is making moves to transition to cloud;...

Read more

Aspen Dental: How Dental Checkups Are Vital for One’s Oral Health in Mobile

June 4, 2024 11:00 AM

NEW YORK, NY / ACCESSWIRE / June 4, 2024 / As the oldest city in Alabama and the birthplace of Mardi Gras, Mobile is an exciting destination with plenty to do. And the more time people spend in the cultural center of the Gulf Coast, the more time they'll have to savor the local cuisine and visit the sites. With so much excitement, oral health can take a back seat. But dental checkups are critical to maintaining oral health for individuals and...

Read more

Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock

June 4, 2024 9:50 AM

REDWOOD CITY, CA / ACCESSWIRE / June 4, 2024 / Biotricity Inc.] (NASDAQ:BTCY), a leading Technology-as-a-Service (TaaS) company dedicated to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, is thrilled to announce that the majority of its existing Preferred A shareholders have converted 97% of all the preferred A shares into Restricted Common Stock, increasing their support and commitment to the...

Read more

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

June 4, 2024 9:00 AM

Champions Oncology, Inc. (Nasdaq:CSBR), a leader in the development of advanced preclinical oncology solutions, has announced a strategic partnership with Medicines Discovery Catapult (MDC), enhancing their combined capabilities in the expanding field of radiopharmaceutical therapeutics.This collaboration combines Champions Oncology's robust portfolio of patient-derived models and pharmacology solutions with MDC's expertise in radio-conjugates,...

Read more

KindlyMD to Present at the KCSA Cannabis Virtual Investor Conference on June 5th

June 4, 2024 9:00 AM

SALT LAKE CITY, UT / ACCESSWIRE / June 4, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or "the Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory...

Read more

AGC Biologics Completes Copenhagen Campus Expansion, Doubling Single-use Mammalian Bioreactor Capacity at Site

June 4, 2024 8:00 AM

AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced at BIO International the completion of its new manufacturing building at the AGC Biologics Copenhagen campus. The completed work doubles the site's single-use bioreactor capacity for mammalian services and allows it to produce 150 more batches of drug product each year.The expansion adds 19,000 m2 of space in an...

Read more

Saint Therese To Transition Its New Hope Senior Community to New Ownership

June 4, 2024 8:00 AM

After years of intensive research and deliberation about the future of its New Hope senior living community, aging services provider Saint Therese today announced it is transitioning Saint Therese of New Hope to new ownership, supported by senior care provider Compass Healthcare. The transition is expected to be final on August 1, 2024 and the name will change to Woodlake Care Center and Woodlake Residences."This was a very difficult decision...

Read more

Ankle & Foot Centers of America Welcomes Dr. Amish Dudeja, DPM, Johns Creek Foot Surgeon

June 4, 2024 8:00 AM

Using a patient-centered approach, Dudeja adds quality podiatric care for foot and ankle conditions at the Johns Creek office.JOHNS CREEK, GA / ACCESSWIRE / June 4, 2024 / Ankle & Foot Centers of America, a leading group in the field of podiatry, is thrilled to announce the addition of Dr. Amish Dudeja, DPM, to their physician team in Johns Creek, GA. Dr. Dudeja brings a wealth of knowledge and an impressive track record in podiatric medicine...

Read more

FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication

June 4, 2024 7:30 AM

TORONTO, ON / ACCESSWIRE / June 4, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today confirms that it has received institutional review board (IRB) approval for its METAL-2 trial in the USA. This IRB approval allows our team to begin recruiting clinical trial...

Read more

Theralase(R) Technology Effective in Virus Inactivation

June 4, 2024 7:00 AM

Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated small molecules for the safe and effective destruction of various cancers, bacteria and viruses, is pleased to announce that it's lead compound, RuvidarTM, has been proven effective in the inactivation of various viruses.The research was...

Read more

Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels

June 4, 2024 6:30 AM

ANN ARBOR, MI / ACCESSWIRE / June 4, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for equine and companion animals, completed the expansion of its global manufacturing and distribution facilities in Roswell, Georgia. The expansion, which increases the facility's total size to 18,400 sq. ft., adding 6,000 sq. ft. of adjacent space, enhances...

Read more

The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for Strong Antiviral Effect

June 4, 2024 6:30 AM

NanoViricides, Inc. (NYSE Amer.:NNVC) (the "Company"), a clinical-stage global leader in broad-spectrum antiviral nanomedicines, reports on the highly desirable blood concentration profile of its lead clinical stage broad-spectrum antiviral agent NV-387 upon intravenous (I.V.) administration in a non-human primate (NHP) animal model.The Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a...

Read more

Amphastar Announces Additional $50 Million Increase to its Share Buyback Program

June 4, 2024 6:00 AM

RANCHO CUCAMONGA, CA / ACCESSWIRE / June 4, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) today announced that on June 3, 2024, the Company's Board of Directors authorized a $50 million increase to the Company's share buyback program, which is expected to continue for an indefinite period of time. The primary goal of the program is to offset dilution created by the Company's equity compensation programs.Purchases may be made through the...

Read more

Regulatory Expert Appointed to Lead West Coast US Client Engagement for G&L Healthcare Advisors

June 3, 2024 5:00 PM

MADISON, NJ / ACCESSWIRE / June 3, 2024 / G&L Healthcare Advisors is delighted to announce that Richard Edmunds, a 25-year veteran in regulatory affairs, will take on a new client engagement role and lead our U.S. West Coast business expansion, based out of G&L's San Diego, California, office. Richard Edmunds, G&L Healthcare Advisors Richard Edmunds, G&L Healthcare Advisors Bringing decades of regulatory and clinical development experience,...

Read more

KindlyMD Announces Closing of $6.8 Million Initial Public Offering

June 3, 2024 11:00 AM

SALT LAKE CITY, UT / ACCESSWIRE / June 3, 2024 / KindlyMD, Inc. (NASDAQ:KDLY)(NASDAQ:KDLYW) ("KindlyMD" or the "Company"), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, including the recommendation of medical cannabis in patient treatment plans in compliance with a legalized state medical cannabis regulatory...

Read more